Skip navigation
Perelman School of Medicine at the University of Pennsylvania gtp-logo_ColorKnockoutNavy GENE THERAPY PROGRAM Navigate to home page
  • Home
  • About Us
  • The Wilson Lab
  • Vector Core
  • Our Team
  • News
  • Publications
  • Careers
  • Contact

Filter by year:

  • 1995
  • 1996
  • 1998
  • 2005

Filter by author:

  • Albelda SM
  • Amin KM
  • Cheung L
  • Coonrod L
  • DeLong P
  • Elshami AA
  • Engelhardt JF
  • Goldman MJ
  • Kaiser LR
  • Knox L
  • Kucharczuk JC
  • Deselect Litzky LA
  • Molnar-Kimber K
  • Raper S
  • Recio A
  • Sterman DH
  • Sun J
  • Treat J
  • Vachani A
  • Wheeldon EB
  • Wilson JM

Publication 10/15/2005

Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy.

Sterman DH, Recio A, Vachani A, Sun J, Cheung L, DeLong P, Amin KM, Litzky LA, Wilson JM, Kaiser LR, Albelda SM

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research

Publication 5/01/1998

Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.

Sterman DH, Treat J, Litzky LA, Amin KM, Coonrod L, Molnar-Kimber K, Recio A, Knox L, Wilson JM, Albelda SM, Kaiser LR

Human Gene Therapy

Publication 12/01/1996

Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primates.

Kucharczuk JC, Raper S, Elshami AA, Amin KM, Sterman DH, Wheeldon EB, Wilson JM, Litzky LA, Kaiser LR, Albelda SM

Human Gene Therapy

Publication 7/01/1995

Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: a preclinical toxicology study.

Goldman MJ, Litzky LA, Engelhardt JF, Wilson JM

Human Gene Therapy